carbamates has been researched along with Left Ventricular Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aluja, D | 1 |
| Inserte, J | 1 |
| Penela, P | 1 |
| Ramos, P | 1 |
| Ribas, C | 1 |
| Iñiguez, MÁ | 1 |
| Mayor, F | 1 |
| Garcia-Dorado, D | 1 |
| Pombo, M | 1 |
| Olalla, J | 1 |
| Del Arco, A | 1 |
| De La Torre, J | 1 |
| Urdiales, D | 1 |
| Aguilar, A | 1 |
| Prada, JL | 1 |
| García-Alegría, J | 1 |
| Ruiz-Mateas, F | 1 |
2 other studies available for carbamates and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Calpains mediate isoproterenol-induced hypertrophy through modulation of GRK2.
Topics: Animals; Calpain; Carbamates; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 2; Hypertrop | 2019 |
Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Carba | 2013 |